E van Poelgeest - JoVE Visualize

Showing results (61-70 of 81) with videos related to

Pageof 9

Sort By:

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2024

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, et al.

International Journal of Cancer|January 14, 2014

Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapyE M G van Esch, B Tummers, V Baartmans, et al.

British Journal of Cancer|July 28, 2023

Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide studyNoortje Pleunis, Anne-Floor W Pouwer, Maaike H M Oonk, et al.

British Journal of Clinical Pharmacology|May 11, 2026

Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trialLaura W J van der Meulen, Menthe E Bergmans, Salma Assil, et al.

International Journal of Cancer|April 12, 2008

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasiaMuriel van den Hende, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.

Oncotarget|March 26, 2016

Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17Quirijn R J G Tummers, Charlotte E S Hoogstins, Katja N Gaarenstroom, et al.

Journal for Immunotherapy of Cancer|January 18, 2022

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumorsChantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, et al.

Cancer Immunology, Immunotherapy : CII|September 14, 2016

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancerMariëtte I E van Poelgeest, Valeria V Visconti, Zohara Aghai, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancerE M Dijkgraaf, S J A M Santegoets, A K L Reyners, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018

The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects SurvivalSaskia J Santegoets, Vanessa J van Ham, Ilina Ehsan, et al.

Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:

Pageof 9

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 23, 2024

APOLLO: neo-adjuvant pembrolizumab for primary vulvar squamous cell carcinoma-a multicenter, single-arm, phase II, clinical proof-of-concept studyM I E van Poelgeest, Kim E Kortekaas, Helena C van Doorn, et al.

International Journal of Cancer|January 14, 2014

Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapyE M G van Esch, B Tummers, V Baartmans, et al.

British Journal of Cancer|July 28, 2023

Incidence of inguinofemoral lymph node metastases at the first local recurrence of vulvar cancer: a Dutch nationwide studyNoortje Pleunis, Anne-Floor W Pouwer, Maaike H M Oonk, et al.

British Journal of Clinical Pharmacology|May 11, 2026

Lack of improvement after short-term topical antistaphylococcal endolysin SA.100 therapy in patients with mild-to-moderate atopic dermatitis: Results from a randomized, vehicle-controlled trialLaura W J van der Meulen, Menthe E Bergmans, Salma Assil, et al.

International Journal of Cancer|April 12, 2008

Skin reactions to human papillomavirus (HPV) 16 specific antigens intradermally injected in healthy subjects and patients with cervical neoplasiaMuriel van den Hende, Mariëtte I E van Poelgeest, Jeanette M van der Hulst, et al.

Oncotarget|March 26, 2016

Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17Quirijn R J G Tummers, Charlotte E S Hoogstins, Katja N Gaarenstroom, et al.

Journal for Immunotherapy of Cancer|January 18, 2022

CD161 expression and regulation defines rapidly responding effector CD4+ T cells associated with improved survival in HPV16-associated tumorsChantal L Duurland, Saskia J Santegoets, Ziena Abdulrahman, et al.

Cancer Immunology, Immunotherapy : CII|September 14, 2016

Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancerMariëtte I E van Poelgeest, Valeria V Visconti, Zohara Aghai, et al.

Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 29, 2015

A phase I trial combining carboplatin/doxorubicin with tocilizumab, an anti-IL-6R monoclonal antibody, and interferon-α2b in patients with recurrent epithelial ovarian cancerE M Dijkgraaf, S J A M Santegoets, A K L Reyners, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018

The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects SurvivalSaskia J Santegoets, Vanessa J van Ham, Ilina Ehsan, et al.

Pageof 9